Proffitt & Goodson’s Bristol-Myers Squibb BMY Stock Holding History

Proffitt & Goodson’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$76.6K	Hold	1,330	–	–	0.01%	172
2026 Q1	$80.7K	Sell	1,330 -128	-9%	-$7.46K	0.01%	166
2025 Q4	$78.6K	Hold	1,458	–	–	0.01%	160
2025 Q3	$65.8K	Hold	1,458	–	–	0.01%	161
2025 Q2	$67.5K	Buy	+1,458	New	+$71.6K	0.01%	153

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Proffitt & Goodson's BMY Position: Q2 2026 in Review

Proffitt & Goodson held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,330 shares worth $76.6K. The position accounts for 0.01% of the portfolio, ranked #172.

Proffitt & Goodson first reported a position in BMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $80.7K in Q1 2026. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Proffitt & Goodson held 1,330 shares of Bristol-Myers Squibb worth $76.6K as of Q2 2026.
Proffitt & Goodson left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.01% of Proffitt & Goodson's portfolio in Q2 2026, its #172 holding.
Proffitt & Goodson first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 5 quarters since.
Proffitt & Goodson's Bristol-Myers Squibb position peaked at $80.7K in Q1 2026.
1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Proffitt & Goodson's 13F filing for Q2 2026, filed 22 Jul 2026.